FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385874397> ?p ?o ?g. }

• W4385874397 abstract "Abstract Objective Pharmacological inhibition of the renin-angiotensin-aldosterone-system (RAASi) is the cornerstone of hypertension treatment, renoprotection and secondary prevention of cardiovascular disease in patients with type 2 diabetes. Although there is a dose-dependent effect of RAASi with optimum protection when using maximal dose, little is known on actual use of maximal dosage RAASi in clinical practice. Here we investigate prevalence of maximal dosage RAASi, and contraindications for, optimizing RAASi dosage, in patients with complicated type 2 diabetes in a real-life clinical setting. Research design and methods We performed a retrospective analysis in 668 patients included in the DIAbetes and LifEstyle Cohort Twente (DIALECT). We grouped patients according to no RAASi, submaximal RAASi and maximal RAASi use. All potassium and creatinine measurements between January 1st 2000 and date of inclusion in DIALECT were extracted from patients files. We identified determinants of maximal RAASi use vs. submaximal RAASi use with multivariate logistic regression analysis. Results Mean age was 64 ± 10 years and 61% were men. In total, 460 patients (69%) used RAASi, and 30% used maximal RAASi. Maximal RAASi use was not statistically different between different indications for RAASi (i.e. hypertension, diabetic kidney disease, coronary heart disease and cerebrovascular disease; P > 0.05). Per patient, 2 [1-4] measurements of potassium and 20 [13–31] measurements of creatinine were retrieved, retrospective follow-up time was − 3.0 [-1.4 to -5.7] years. Pre-baseline hyperkalemia > 5.0 mmol/l and acute kidney injury were found in 151 (23%) patients and 119 patients (18%), respectively. Determinants of maximal RAASi were prior acute kidney injury (OR 0.51 (0.30–0.87)), increased albuminuria (OR 1.89 (1.17–3.08)) and total number of used antihypertensives (OR 1.66 (1.33–2.06)). Conclusions Maximal dose RAASi is used in almost one third of complicated type 2 diabetes patients in a real-life setting. The prevalence of contraindications is considerable, but relative in nature, suggesting that it is worthwhile to explore strategies aimed at maximizing RAASi while circumventing the alleged contraindications." @default.
• W4385874397 created "2023-08-17" @default.
• W4385874397 creator A5010367070 @default.
• W4385874397 creator A5038949732 @default.
• W4385874397 creator A5048502406 @default.
• W4385874397 creator A5065785268 @default.
• W4385874397 creator A5075188709 @default.
• W4385874397 creator A5089924058 @default.
• W4385874397 creator A5090537014 @default.
• W4385874397 date "2023-08-16" @default.
• W4385874397 modified "2023-10-06" @default.
• W4385874397 title "Use of maximal dosage renin-angiotensin-aldosterone system inhibitors in a real life population of complicated type 2 diabetes – contraindications and opportunities" @default.
• W4385874397 cites W1592634771 @default.
• W4385874397 cites W1967754661 @default.
• W4385874397 cites W1972168338 @default.
• W4385874397 cites W1973663762 @default.
• W4385874397 cites W2001933911 @default.
• W4385874397 cites W2044773944 @default.
• W4385874397 cites W2056976690 @default.
• W4385874397 cites W2078265054 @default.
• W4385874397 cites W2104099864 @default.
• W4385874397 cites W2113390437 @default.
• W4385874397 cites W2113760558 @default.
• W4385874397 cites W2126120464 @default.
• W4385874397 cites W2150959326 @default.
• W4385874397 cites W2182000067 @default.
• W4385874397 cites W2475261460 @default.
• W4385874397 cites W2726919964 @default.
• W4385874397 cites W2770837559 @default.
• W4385874397 cites W2888589263 @default.
• W4385874397 cites W2899235478 @default.
• W4385874397 cites W3011371150 @default.
• W4385874397 cites W3021250193 @default.
• W4385874397 doi "https://doi.org/10.1186/s12882-023-03205-2" @default.
• W4385874397 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37587437" @default.
• W4385874397 hasPublicationYear "2023" @default.
• W4385874397 type Work @default.
• W4385874397 citedByCount "0" @default.
• W4385874397 crossrefType "journal-article" @default.
• W4385874397 hasAuthorship W4385874397A5010367070 @default.
• W4385874397 hasAuthorship W4385874397A5038949732 @default.
• W4385874397 hasAuthorship W4385874397A5048502406 @default.
• W4385874397 hasAuthorship W4385874397A5065785268 @default.
• W4385874397 hasAuthorship W4385874397A5075188709 @default.
• W4385874397 hasAuthorship W4385874397A5089924058 @default.
• W4385874397 hasAuthorship W4385874397A5090537014 @default.
• W4385874397 hasBestOaLocation W43858743971 @default.
• W4385874397 hasConcept C126322002 @default.
• W4385874397 hasConcept C134018914 @default.
• W4385874397 hasConcept C164705383 @default.
• W4385874397 hasConcept C2777180221 @default.
• W4385874397 hasConcept C2778653478 @default.
• W4385874397 hasConcept C2908647359 @default.
• W4385874397 hasConcept C555293320 @default.
• W4385874397 hasConcept C71924100 @default.
• W4385874397 hasConcept C99454951 @default.
• W4385874397 hasConceptScore W4385874397C126322002 @default.
• W4385874397 hasConceptScore W4385874397C134018914 @default.
• W4385874397 hasConceptScore W4385874397C164705383 @default.
• W4385874397 hasConceptScore W4385874397C2777180221 @default.
• W4385874397 hasConceptScore W4385874397C2778653478 @default.
• W4385874397 hasConceptScore W4385874397C2908647359 @default.
• W4385874397 hasConceptScore W4385874397C555293320 @default.
• W4385874397 hasConceptScore W4385874397C71924100 @default.
• W4385874397 hasConceptScore W4385874397C99454951 @default.
• W4385874397 hasFunder F4320323906 @default.
• W4385874397 hasIssue "1" @default.
• W4385874397 hasLocation W43858743971 @default.
• W4385874397 hasLocation W43858743972 @default.
• W4385874397 hasLocation W43858743973 @default.
• W4385874397 hasOpenAccess W4385874397 @default.
• W4385874397 hasPrimaryLocation W43858743971 @default.
• W4385874397 hasRelatedWork W1563850031 @default.
• W4385874397 hasRelatedWork W2045367862 @default.
• W4385874397 hasRelatedWork W2111970376 @default.
• W4385874397 hasRelatedWork W2412727020 @default.
• W4385874397 hasRelatedWork W2415759662 @default.
• W4385874397 hasRelatedWork W2981884515 @default.
• W4385874397 hasRelatedWork W3003571257 @default.
• W4385874397 hasRelatedWork W3036934084 @default.
• W4385874397 hasRelatedWork W4377262157 @default.
• W4385874397 hasRelatedWork W1556208436 @default.
• W4385874397 hasVolume "24" @default.
• W4385874397 isParatext "false" @default.
• W4385874397 isRetracted "false" @default.
• W4385874397 workType "article" @default.